Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

par Gisslinger, Heinz, Gotic, Mirjana, Holowiecki, Jerzy, Penka, Miroslav, Thiele, Juergen, Kvasnicka, Hans-Michael, Kralovics, Robert, Petrides, Petro E., Gastl, G., Gisslinger, B., Muellauer, L., Schlögl, E., Indrak, K., Pytlik, R., Briere, J., Kiladjian, J.J., Beykirch, M., Gaede, B., Griesshammer, M., Herbrik-Zipp, M., Hurtz, H.J., Jacobs, G., Jäcki, S.H., Keilholz, U., Mezger, J., Schlag, P., Schriever, F., Masszi, T., Sacchi, S., Griniptì, R., Tavoriene, I., Dmoszynska, A., Hellman, A., Jedrzejczak, W.W., Robak, T., Skotnicki, A., Goh, Y.T., Cernelc, P.
Publié 2013